Last updated: February 13, 2023
Sponsor: Tovah Burstein
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mccune-albright Syndrome
Bone Neoplasm
Bone Diseases
Treatment
N/AClinical Study ID
NCT03231644
Pro00018980.
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria any one or more of the following:
clinical diagnosis of fibrous dysplasia
clinical diagnosis of McCune-Albright syndrome
clinical diagnosis of Mazabraud's syndrome
Study Design
Total Participants: 600
Study Start date:
October 31, 2016
Estimated Completion Date:
October 31, 2026
Study Description
Connect with a study center
Tovah Burstein
Bethesda, Maryland 20816-2558
United StatesActive - Recruiting
FDMASRegistry.org
Grandville, Michigan 49418
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.